Bentham IMF Limited positioning to profit from Forge Group Limited collapse

Bentham IMF looks attractive for long-term investors at current prices.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bentham IMF Limited (ASX: IMF) today announced that it "proposes to fund claims of certain Forge shareholders against Forge and/or its directors and officers." As everyone should know by now, Forge Group Limited (ASX: FGE) collapsed recently, on the back of poor risk management, highly questionable disclosure and overly generous incentives to the CEO.

Although the share price has barely moved since my purchase, becoming a shareholder in Bentham IMF is already beginning to pay off, because I'm proud to be a part owner of a company that fights for justice. Admittedly, Bentham IMF will only go ahead with the claim if Forge is likely to have the ability to pay and if the likelihood of winning is sufficient to justify the risk.

However, at the end of the day, there is more to life than money and the satisfaction I get out of knowing that Forge shareholders have a chance of getting some of their money back is valuable in itself. Of course, there is also the fact that demand for Bentham IMF's services is driven by corporate misconduct. As much as I hope I'm wrong (for society's sake), I'm forecasting that corporate misconduct will continue until society collapses and I expect I'll make some capital gains in due course.

The funny thing about Bentham IMF is that the share price moves almost every time they announce a new case, or the results of an existing case, as if the intrinsic value of the business is dependent on a single case. Of course, if your investment horizon is one year, that might be true, but for long-term investors the real question is whether the company will be able to successfully expand its operations overseas.

I expect the company will pay a fully franked dividend of 5.8% at current prices. However, the dividend tends to vary widely because earnings are lumpy and Bentham IMF needs to maintain a hefty cash reserve so that the big companies it sues don't get any ideas about bleeding the litigation funder dry. So don't assume that they can run down their cash reserves much or anytime soon, despite the fact that the company recently reported $85 million of cash on the balance sheet.

The company did raise capital not long ago at $1.70 per share in order to ensure they could redeem all the convertible notes on issue and fund their operations in the USA. Over 2.2 million of those notes were converted rather than redeemed, so there is a little extra cash available. It's early days yet for the company's US operations, with the recent half yearly showing income of just $66,000 from the US and US exposure of just under $7.4 million. Due to the lengthy process of litigation and negotiation, it will take quite some time before we know if the company is as successful in the USA as it has proven to be in Australia.

Foolish takeaway 

Bentham IMF may not be about to shoot the lights out, but I bought shares at around current prices because I believe corporate skullduggery will continue to create opportunities for Bentham IMF to profit over the long term. As long as lawyers and citizens in Australia and the USA continue to demand a properly function justice system, I believe that the business model will continue to work well. Shareholders must also keep in mind that much rests on the current management, who are intelligent and trustworthy, according to those who deal with them.

Although Bentham IMF shares have not dropped to "no-brainer" levels, I find them one of the most attractive options on the ASX at current prices. Indeed, the future seems bright for the company as the current Australian government is in the process of unwinding the Future of Financial Advice reforms. The new rules, will likely allow advisers to proffer advice that is not in the best interests of clients and may lead to further business for the company. After all, Bentham IMF profits when others fall.

Motley Fool contributor Claude Walker (@claudedwalker) owns shares in Bentham IMF and welcomes your feedback.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »